인쇄하기
취소
|
The two amendments on the pricing system for global innovative and biopharmaceutical drugs and the market drug price reduction system, which drew focused interests of the pharmaceutical industry from the beginning of the year, was finally unveiled.
On the 7th, the Ministry of Health and Welfare(MOHW) held the ‘Innovative Pharmaceutical Company CEOs’ Meeting,’ and announced the ‘2016 New Certif...